HOME >> BIOLOGY >> NEWS
Antibiotic resistance markers in GM plants not a risk to human health

Antibiotic-resistance markers in genetically modified (GM) plants do not pose a substantial risk to human health, concludes a review article published in the October issue of The Lancet Infectious Diseases.

Antibiotic resistance marker genes are used as a tool to recognise the successful introduction into plant cells of a new gene with beneficial characteristics. The markers are coupled with the new gene, so by selecting those cells that express the resistance marker, the cells that have incorporated the gene of interest into their DNA can be identified. Plants derived from these cells neither contain nor produce antibiotics.

The issue of the safety of incorporating antibiotic-resistance markers into GM plants has been a matter of public debate since the early stages of their development. Concern has surrounded the possibility that antibiotic-resistance genes might be passed from GM plants to bacteria, thus creating bacteria that are resistant to antibiotics such as those used to treat common skin, ear, and eye infections.

In this review, authors Stephen Gillespie (University College, London) and Philippe Gay evaluate the scientific evidence regarding the impact of antibiotic-resistance markers on human health. They consider the biological barriers to the transfer of antibiotic-resistance markers into bacteria that cause disease in animals and humans, and the possible clinical consequences of this transfer.

The authors conclude that whereas there is no evidence that antibiotic resistance from GM crops is being transferred to bacteria, this does not exclude the possibility that it might occur. However, the evidence suggests that, if it occurs at all, the contribution to the burden of antibiotic resistance from GM plants is low, and is dwarfed by inappropriate prescribing of antibiotics in medical practice and their use as animal growth promoters in agriculture.

Professor Gillespie comments: "antibiotic-resistance markers do
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
+1-212-633-3810
Lancet
27-Sep-2005


Page: 1 2

Related biology news :

1. Antibiotic stress, genetic response and altered permeability of E. coli
2. Antibiotic treats lymphoma of the eye
3. Antibiotic inhibits cancer gene activity
4. Antibiotics may not be enough to stop recurrent gastric lymphoma caused by Helicobacter pylori
5. Antibiotics help combat dangerous tropical disease
6. Antibiotic resistant bacterium uses Sonar-like strategy to see enemies or prey
7. Antibiotic-resistant bacteria increased after clindamycin use for common vaginal infection
8. Antibiotic identified as potential anti-cancer candidate
9. Support for chromosomal theory of cancer found in cancers development of drug resistance
10. 454 sequencing identifies HIV drug resistance at early stage
11. Ultra deep sequencing identifies HIV drug resistance at early stage

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2020)... ... May 06, 2020 , ... The ... become the latest out-of-state company to partner with the device accelerator located ... developed a point-of-care analyzer capable of accurately performing enzyme-linked immunosorbent assays (ELISAs), ...
(Date:5/1/2020)... ... April 30, 2020 , ... ... diseases, announced today that it had been awarded a contract from the Biomedical ... Secretary for Preparedness and Response at the U.S. Department of Health and Human ...
(Date:4/30/2020)... , ... April 28, 2020 , ... ... are Lachman Consultants latest effort in providing timely and critical information to life ... by social distancing and health safety concerns. , “Providing the most up-to-date actionable ...
Breaking Biology News(10 mins):
(Date:5/28/2020)... , ... May 28, 2020 , ... The Security ... security leaders as the 2020 winners of the Women in Biometrics Awards ... IDEMIA , Biometric Update and the SIA Women in Security ...
(Date:5/21/2020)... ... May 19, 2020 , ... Experienced periodontist in Eden ... dental implants and bone grafting through PIEZOSURGERY® technology. PIEZOSURGERY uses ultrasonic vibrations ... used to prepare a patient for dental implants, especially when the implants need to ...
(Date:5/15/2020)... ... May 14, 2020 , ... ... cell banks and hMSC bioprocess systems, today announced the launch of its ... extracellular vesicles (EVs). RoosterCollect™-EV-CC is the only system designed with hMSC-EV product ...
(Date:5/15/2020)... ... May 15, 2020 , ... Sentien Biotechnologies, Inc., a ... Richard Ganz as Executive Chairman. Mr. Ganz will continue to lead Sentien’s Board ... as work closely with CEO Brian Miller and Sentien’s management team. , ...
Breaking Biology Technology:
Cached News: